Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Myosin ATPase Inhibitor 2,3-Butanedione monoxime Dictates Transcriptional Activation of Ion Channels and Ca2+-Handling Proteins

Jürgen Borlak and Carolin Zwadlo
Molecular Pharmacology September 2004, 66 (3) 708-717;
Jürgen Borlak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolin Zwadlo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 66 no. 3 708-717
PubMed 
15322264

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 14, 2004
  • Accepted June 16, 2004
  • Published online August 20, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jürgen Borlak and
  2. Carolin Zwadlo
  1. Fraunhofer Institute of Toxicology and Experimental Medicine, Centre for Drug Research and Medical Biotechnology, Hannover, Germany
  1. Address correspondence to:
    Prof. Dr. Jürgen Borlak, Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, D-30659 Hannover, Germany. E-mail: borlak{at}item.fraunhofer.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2004 to January 2023

AbstractFullPdf
Aug 2004264812
Sep 20043011114
Oct 2004394710
Nov 2004284731
Dec 2004262911
Jan 200526366
Feb 200514131
Mar 200513156
Apr 20052266
May 200593210
Jun 200511208
Jul 200563612
Aug 20057173
Sep 200552215
Oct 200510238
Nov 200510135
Dec 20058192
Jan 200616298
Feb 200611192
Mar 20069174
Apr 20064112
May 20067568
Jun 200610163
Jul 20067205
Aug 20067144
Sep 20062188
Oct 20063210
Nov 200622514
Dec 20065176
Jan 20075306
Feb 20073267
Mar 200725413
Apr 200795811
May 20074323
Jun 20075403
Jul 20075286
Aug 20076359
Sep 20074206
Oct 200712265
Nov 200712357
Dec 20076177
Jan 20086299
Feb 2008162411
Mar 2008142410
Apr 200817498
May 2008173113
Jun 2008274913
Jul 2008192612
Aug 200822235
Sep 2008198917
Oct 200812528
Nov 20085278
Dec 200810225
Jan 200912298
Feb 2009182310
Mar 200916449
Apr 2009116012
May 20094303
Jun 200918386
Jul 200912459
Aug 200910446
Sep 2009116010
Oct 200911494
Nov 200917447
Dec 200915436
Jan 20105409
Feb 201010408
Mar 20103324
Apr 201012546
May 20108686
Jun 20107548
Jul 201020507
Aug 2010136514
Sep 20105739
Oct 2010166814
Nov 20104647
Dec 201013446
Jan 2011174113
Feb 20119378
Mar 201110539
Apr 201193611
May 20116399
Jun 201110237
Jul 201111237
Aug 201143311
Sep 201162210
Oct 201175211
Nov 2011105711
Dec 201162515
Jan 201282516
Feb 2012112427
Mar 201284015
Apr 2012114419
May 2012102413
Jun 2012162015
Jul 2012173515
Aug 2012174415
Sep 201217374
Oct 2012265612
Nov 2012213221
Dec 2012161810
Jan 2013254419
Feb 201319308
Mar 201318308
Apr 2013267024
May 20139189
Jun 20134187
Jul 20137219
Aug 201391913
Sep 201362610
Oct 201331519
Nov 20137278
Dec 20136127
Jan 201413206
Feb 201482012
Mar 201442715
Apr 201457012
May 20142296
Jun 20148246
Jul 20142394
Aug 20141334
Sep 20144286
Oct 201474011
Nov 201411329
Dec 201494214
Jan 201534115
Feb 201523412
Mar 201584510
Apr 201567917
May 2015102912
Jun 201562911
Jul 201543513
Aug 2015103912
Sep 201533811
Oct 201512311
Nov 201552012
Dec 201522513
Jan 201632616
Feb 201622618
Mar 201676522
Apr 201676716
May 201622322
Jun 201634619
Jul 201652210
Aug 20161316
Sep 201662314
Oct 20163318
Nov 20161304
Dec 20165192
Jan 20170152
Feb 20171272
Mar 20170234
Apr 20171251
May 20170182
Jun 20170210
Jul 20172246
Aug 20172243
Sep 20173131
Oct 20171278
Nov 20170258
Dec 20171163
Jan 20180182
Feb 20181213
Mar 20182234
Apr 20180375
May 20180235
Jun 20182214
Jul 201832111
Aug 20180142
Sep 20180254
Oct 20182875
Nov 20180816
Dec 20183170
Jan 20195800
Feb 20194620
Mar 20191932
Apr 20191650
May 20191200
Jun 20191002
Jul 2019221
Aug 20191800
Sep 2019610
Oct 20192570
Nov 20191940
Dec 20192200
Jan 20201300
Feb 20201000
Mar 20201100
Apr 2020800
May 2020210
Jun 2020400
Jul 2020600
Aug 2020900
Sep 2020700
Oct 20201910
Nov 20201000
Dec 2020700
Jan 2021620
Feb 2021410
Mar 2021910
Apr 2021811
May 20213022
Jun 2021810
Jul 2021810
Aug 20211510
Sep 2021520
Oct 2021921
Nov 2021911
Dec 2021210
Jan 2022910
Feb 2022250
Mar 2022210
Apr 2022620
May 20221242
Jun 20221421
Jul 20221510
Aug 2022710
Sep 2022210
Oct 20221120
Nov 2022810
Dec 2022110
Jan 2023510

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 66 (3)
Molecular Pharmacology
Vol. 66, Issue 3
1 Sep 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Myosin ATPase Inhibitor 2,3-Butanedione monoxime Dictates Transcriptional Activation of Ion Channels and Ca2+-Handling Proteins
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Myosin ATPase Inhibitor 2,3-Butanedione monoxime Dictates Transcriptional Activation of Ion Channels and Ca2+-Handling Proteins

Jürgen Borlak and Carolin Zwadlo
Molecular Pharmacology September 1, 2004, 66 (3) 708-717;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Myosin ATPase Inhibitor 2,3-Butanedione monoxime Dictates Transcriptional Activation of Ion Channels and Ca2+-Handling Proteins

Jürgen Borlak and Carolin Zwadlo
Molecular Pharmacology September 1, 2004, 66 (3) 708-717;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics